The Surgical Fluorescence Imaging System is a surgical guidance system that uses a drug-device combination approach. It employs indocyanine green (ICG) as a fluorescence probe, relying on "ultra-high sensitivity" and combining the optical properties of ICG in submillimeter-size tumors to provide surgeons with high-definition visible light, fluorescence imaging, and quantitative data for diagnostic information during tumor surgery. It is suitable for real-time observation of tissues (such as tumor tissue, margin tissue), blood supply (free skin flap), lymph nodes (sentinel lymph nodes, regional lymph nodes), and anatomical structures (liver segments, gallbladder, lung segments).

• 1
  Ultra-low fluorescence detection limit: Real-time diagnosis of millimeter-sized tumors during surgery, decreasing detection limits to sub-millimeter levels.
• 2
  Dual Quantitative Analysis: ROI Value and Independent Spectral Digitization provide objective numerical judgment for imaging diagnostic information.
• 3
  Pseudo-color grading analysis system: Objectively presents the concentration gradient of the tracer in target tissue.
• 4
  Multi-Mode Imaging: Support for 7 types including AI Assisted Boundary Sharpening and Real-time fusion.

Used for tumor localization, margin assessment, blood supply to transplanted flaps, and sentinel lymph node localization.

Tumor localization

Margin assessment

Blood supply assessment

Research hotspot

Identification of parathyroid glands, lymphatic mapping of sentinel nodes, and real-time tumor identification during breast-conserving surgery.

Lymphatic mapping

Tumor identification

Gland identification

Margin assessment

Functional evaluation

Blood supply evaluation

Used for liver segment staining, biliary tract visualization, and real-time localization of metastases in liver, kidney, and adrenal surgeries.

Liver segment staining

Lymphatic tracing

Tumor identification

Margin determination

Biliary tract staining

Anastomotic evaluation